miR-214-3p Attenuates Sepsis-Induced Myocardial Dysfunction in Mice by Inhibiting Autophagy through PTEN/AKT/mTOR

Zhenzhen Sang1,2, Pu Zhang1, Yunxia Wei1

  • 1Emergency Department, The Third Hospital of Hebei Medical University, No. 139 Ziqiang Road, Qiaoxi Qu, Shijiazhuang City 050051, China.

Insights

MicroRNA-214-3p alleviates sepsis-induced myocardial dysfunction by inhibiting cardiac autophagy. This microRNA targets PTEN, offering a potential therapeutic strategy for sepsis-related heart problems.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cellular Biology

Background:

  • Sepsis frequently leads to cardiac dysfunction, known as sepsis-induced myocardial dysfunction (SIMD).
  • Autophagy is implicated in the pathogenesis of SIMD, but its precise role and regulatory mechanisms remain under investigation.
  • MicroRNAs (miRNAs) are emerging as key regulators of cellular processes, including autophagy and cardiac function.

Purpose of the Study:

  • To investigate the role of miR-214-3p in regulating autophagy within the context of SIMD.
  • To determine if miR-214-3p can attenuate cardiac dysfunction in a mouse model of sepsis.
  • To elucidate the molecular mechanisms by which miR-214-3p influences autophagy and myocardial function during sepsis.

Main Methods:

  • A mouse model of sepsis was established using cecal ligation and puncture (CLP).
  • Cardiac structure and function were assessed in septic mice.
  • Myocardial autophagy levels were quantified using immunohistochemistry, immunofluorescence, and Western blot analyses.
  • PTEN expression and the AKT/mTOR pathway were examined in myocardial tissues.

Main Results:

  • miR-214-3p administration attenuated cardiac dysfunction in septic mice.
  • miR-214-3p significantly inhibited myocardial autophagy levels in the heart.
  • The study demonstrated that miR-214-3p suppresses autophagy by silencing PTEN expression, thereby activating the AKT/mTOR pathway.

Conclusions:

  • miR-214-3p exerts a protective effect against SIMD by inhibiting cardiac autophagy through the PTEN/AKT/mTOR signaling pathway.
  • These findings highlight miR-214-3p as a potential therapeutic target for managing sepsis-induced myocardial dysfunction.